NCT02219061

Brief Summary

Maternal antibodies (measles and meningitis C) may wane in the first six months after birth.

  • Geometric mean titers(GMTs) of measles and meningitis C.
  • Follow-up on 0 month, 3rd month,5th month and 7th month after birth.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2014

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2014

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 13, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 18, 2014

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2014

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
Last Updated

September 18, 2014

Status Verified

August 1, 2014

Enrollment Period

5 months

First QC Date

August 13, 2014

Last Update Submit

September 16, 2014

Conditions

Measles

Keywords

MeaslesMeningitis CwaningGeometric Mean TiterChina

Outcome Measures

Primary Outcomes (1)

  • Geometric Mean Titer

    Up to six months

Study Arms (1)

GMT

Eligibility Criteria

AgeUp to 7 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Infants.

You may qualify if:

  • Healthy infants.

You may not qualify if:

  • Infants with poor score.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Guangzhou Center for Disease Control and Prevention

Guangzhou, Guangdong, 510440, China

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

Children's Serum will be collected for measles and meningitis C antibodies test by ELISA method.

MeSH Terms

Conditions

Measles

Condition Hierarchy (Ancestors)

Morbillivirus InfectionsParamyxoviridae InfectionsMononegavirales InfectionsRNA Virus InfectionsVirus DiseasesInfections

Study Officials

  • Ming Wang

    Guangzhou CDC

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Chuanxi Fu, PhD

CONTACT

+86 20 36055887fuchuanxi@gmail.com

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 13, 2014

First Posted

August 18, 2014

Study Start

May 1, 2014

Primary Completion

October 1, 2014

Study Completion

December 1, 2014

Last Updated

September 18, 2014

Record last verified: 2014-08

Locations

CN(1)